STEPHANIE DAVITTO: Open Payments
NPI 1053757047 · WEST LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 74 payments from 13 companies in 2025. Trend: 2023 $780 · 2024 $1,248 · 2025 $1,667
Food & beverage: $1,500Education: $167
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $320 |
| GENZYME CORPORATION | 6 | $220 |
| LEO Pharma Inc. | 11 | $195 |
| ABBVIE INC. | 11 | $173 |
| Incyte Corporation | 5 | $154 |
| UCB, Inc. | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 6 | $115 |
| Amgen Inc. | 5 | $111 |
| Regeneron Healthcare Solutions, Inc. | 5 | $102 |
| Galderma Laboratories, L.P. | 2 | $62 |
Products named: DUPIXENT, TREMFYA, ADBRY, Opzelura, Bimzelx, OTEZLA, RINVOQ, SKYRIZI.
Industry payments across IN — which companies pay providers there.
